# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-090871
Filing Date
2024-08-05
Accepted
2024-08-05 16:41:18
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | etnb-20240630.htm iXBRL | 10-Q | 1774359
2 | EX-10.1 | etnb-ex10_1.htm | EX-10.1 | 179069
3 | EX-31.1 | etnb-ex31_1.htm | EX-31.1 | 14746
4 | EX-31.2 | etnb-ex31_2.htm | EX-31.2 | 14758
5 | EX-32 | etnb-ex32.htm | EX-32 | 15015
| Complete submission text file | 0000950170-24-090871.txt |  | 7836369

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | etnb-20240630.xsd | EX-101.SCH | 1256674
62 | EXTRACTED XBRL INSTANCE DOCUMENT | etnb-20240630_htm.xml | XML | 1252533

Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 241175457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)